VTRS FY 2018 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

FY 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$11.4B-4.0% YoY

Gross Profit

$4.0B35.0% margin

Operating Income

$906M7.9% margin

Net Income

$353M3.1% margin

EPS (Diluted)

$0.68

Cash Flow

Operating Cash Flow

$2.3B

Free Cash Flow

$2.1B

Stock-Based Comp.

-$71M

Balance Sheet

Total Assets

$32.7B

Total Liabilities

$20.6B

Stockholders' Equity

$12.2B

Cash & Equivalents

$388M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11.4B	$11.9B	-4.0%
Gross Profit	$4.0B	$4.8B	-16.3%
Operating Income	$906M	$1.4B	-37.0%
Net Income	$353M	$696M	-49.4%